Actionnariat et activité des initiés pour NuCana plc (NCNA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.30 |
| Capitalisation | $8M |
| Bourse | NASDAQ |
| Pays | GB |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $20.0M | $86.7M | $77.0M | $52.0M | $87.4M | $60.3M | $41.9M | $17.2M | $6.7M | $24.3M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $2.6M | $4.8M | $4.8M | $9.1M | $10.6M | $8.2M | $7.0M | $5.8M | $4.6M | $1.9M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $25.8M | $94.0M | $83.6M | $65.2M | $101.8M | $71.6M | $54.9M | $25.0M | $12.3M | $26.9M |
| Immobilisations Corporelles | $18000 | $358000 | $427000 | $1.1M | $1.2M | $851000 | $866000 | $521000 | $197000 | $658000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $1.4M | $1.9M | $3.1M | $4.0M | $4.8M | $2.4M | $2.4M | $2.1M | $2.2M | $2.2M |
| Actifs Totaux | $27.2M | $96.4M | $87.2M | $70.3M | $107.8M | $77.5M | $58.3M | $27.8M | $14.8M | $29.8M |
| Dettes Fournisseurs | $728000 | $1.1M | $2.5M | $2.4M | $2.3M | $1.8M | $4.8M | $3.4M | $2.7M | $522000 |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $2.0M | $2.9M | $5.6M | $6.2M | $8.1M | $11.7M | $19.3M | $12.7M | $8.7M | $4.8M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $2.0M | $2.9M | $5.6M | $6.7M | $8.6M | $11.9M | $19.8M | $12.9M | $8.8M | $5.5M |
| Réserves | -$22.3M | -$45.2M | -$58.8M | -$80.1M | -$110.6M | -$149.7M | -$180.6M | -$207.7M | -$224.3M | -$252.3M |
| Capitaux Propres | $25.2M | $93.4M | $81.6M | $63.5M | $99.2M | $65.5M | $38.5M | $14.9M | $6.0M | $24.3M |
| Dette Totale | 0 | 0 | 0 | $806000 | $645000 | $371000 | $639000 | $396000 | $190000 | $676000 |
| Dette Nette | -$20.0M | -$86.7M | -$77.0M | -$51.2M | -$86.7M | -$59.9M | -$41.3M | -$16.8M | -$6.6M | -$23.6M |
| Fonds de Roulement | $23.8M | $91.1M | $78.0M | $59.0M | $93.7M | $59.9M | $35.6M | $12.3M | $3.6M | $22.1M |
Santé financière
| Dette / Capitaux propres | 0.03 |
| Ratio de liquidité | 5.60 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -12.10 |
Rentabilité
| Rentabilité des capitaux propres | -120.66% |
| Rentabilité du capital investi | -77.17% |
| Rentabilité des actifs | -98.39% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: CASI · CLGN · CLSD · ENLV · GDTC · LSTA · MTVA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de NCNA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions